Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vexxel Biotech
AddedFeb 18, 2024
UpdatedJun 18, 2026
Vexxel Biotech

Vexxel Biotech

Delaware, Ohio-based medical organization specializing in smart biocapsules for crop enhancement.

HQ
Delaware, OH, US
Founded
2023
Overview
Compare
Fundraising
Employees
Website

Vexxel Biotech, based in Delaware, Ohio, is dedicated to revolutionizing the encapsulation industry with its innovative smart biocapsules. The company's core mission is to enhance crop production through targeted, non-toxic, and biodegradable solutions that are safe for both humans and the environment. Vexxel Biotech aims to replace traditional petrochemical-based capsules with sustainable, cost-effective alternatives that address the stability and cost issues of existing greener options.

Vexxel Biotech has made significant strides in developing its proprietary biocapsules, which have garnered attention for their potential to transform agricultural practices. The company's focus on sustainability and efficiency has positioned it as a leader in the field of smart delivery systems for crop enhancement. By offering a viable and eco-friendly alternative to conventional methods, Vexxel Biotech is contributing to a greener and more sustainable future in agriculture.

Vexxel Biotech - Similar Companies

Capro-X logo

Capro-X

capro-x.com

AgroSpheres logo

AgroSpheres

agrospheres.com

Biodel logo

Biodel

biodelag.com

Capra Biosciences logo

Capra Biosciences

Vulcan Biologics logo

Vulcan Biologics

Agrynex logo

Agrynex

agrynex.us

3Bar Biologics logo

3Bar Biologics

3barbiologics.com

Vitranu logo

Vitranu

vitranu.com

Oerth Bio logo

Oerth Bio

oerthbio.com

Nanosur logo

Nanosur

nanosur.com

EvoAktiv logo

EvoAktiv

evoagtec.com

Strm.Bio logo

Strm.Bio

strm.bio

Intrinsyx Bio logo

Intrinsyx Bio

intrinsyxbio.com

Vella Bioscience logo

Vella Bioscience

vellabio.com

Veloce BioPharma logo

Veloce BioPharma

Vexxel Biotech - Quick Facts

Who are Vexxel Biotech's competitors?

Companies similar to Vexxel Biotech include Capro-X, AgroSpheres, Biodel and Capra Biosciences.

When was Vexxel Biotech founded?

Vexxel Biotech was founded in 2023.

Where is Vexxel Biotech's headquarters located?

Vexxel Biotech's headquarters is located in Delaware, OH, US.

When was Vexxel Biotech's last funding round?

Vexxel Biotech's most recent funding round was for $200k (USD) in August 2023.

How much has Vexxel Biotech raised to-date?

As of Aug 15, 2023, Vexxel Biotech has raised a total of $200k (USD).

How many employees does Vexxel Biotech have?

Vexxel Biotech has 5 employees as of Feb 4, 2024.

Vexxel Biotech - Classification

Industry
  • Agriculture
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biocapsules
  • Crop Enhancement
Tags
  • AgTech
  • Cleantech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified